Neptune, NJ, June 18, 2019… Severe heart attacks can cause an often fatal, but rare condition called cardiogenic shock in which the heart cannot pump enough blood to meet the needs of the body. Hackensack Meridian Health Jersey Shore University Medical Center is using a new method to treat this condition, utilizing an advanced heart pump device, improving survival of patients. Jersey Shore University Medical Center is only the third hospital in New Jersey following treatment protocols outlined by Henry Ford Health System’s National Cardiogenic Shock Initiative and accepted into the collaborative.
“We are excited to share this treatment protocol, cardiogenic team approach and innovative technology with our community. This expands our ability to care for patients successfully in critical, emergency situations,” said Director of the Cardiogenic Shock Initiative at Jersey Shore University Medical Center Aditya Mehra, M.D., FACC, FSCAI. “The initial pilot study of this treatment showed a 50 to 76 percent improvement in patient survival as opposed to using conventional methods. This is the first method to show improvement in survival in more than 20 years. Good news for the approximately 100,000 Americans a year who will suffer cardiogenic shock after a heart attack.”
The treatment process includes standard techniques to open blocked coronary arteries, angioplasty and stent placement, combined with the use of state-of-the-art technology and reduction in medication given to patients. Rapid placement of an Impella heart pump, labeled the world’s smallest by manufacturer ABIOMED, better prepares the patient’s heart to accept treatment and ensure blood is pumped to the rest of the body while allowing recovery. Jersey Shore University Medical Center’s Cardiogenic Shock Team then shares quality data on each patient with the National Cardiogenic Shock Initiative team to continue to develop best practices.
Jersey Shore University Medical Center performs more diagnostic and life-saving interventional cardiac procedures than any other hospital in the region and second most in New Jersey. As a leader in cardiovascular services, the medical center provides the only open and minimally invasive heart surgery program in Monmouth and Ocean counties.
ABIOMED’s Impella Mobile Learning Lab visited Jersey Shore University Medical Center recently, giving cardiac physicians and nurses and other team members an opportunity to learn more about the technology through hands-on learning. Pictured in the lab are members of the cardiogenic shock team, from left is Firas Ajam, M.D.; Arif Asif, M.D.; Adam Kaplan, M.D.; Dawn Calderon, D.O. and Aditya Mehra, M.D., FACC, FSCAI.
ABOUT HACKENSACK MERIDIAN HEALTH JERSEY SHORE UNIVERSITY MEDICAL CENTER
Located in Neptune, New Jersey, Hackensack Meridian Health Jersey Shore University Medical Center is a not-for-profit teaching hospital and the only Level II Trauma and Level II Pediatric Trauma Center in Monmouth and Ocean counties. It is home to K. Hovnanian Children’s Hospital – the first children’s hospital in Monmouth and Ocean counties. With more than 1,200 physicians and dental staff in 60 specialty areas, Jersey Shore University Medical Center’s team provides quality care in a patient-centered, environmentally-friendly setting.
The team’s commitment to excellence has earned Jersey Shore University Medical Center numerous accolades, including being named the #4 hospital in New Jersey by U.S. News & World Report for 2018-2019. The medical center’s clinical research program and longstanding commitment to medical education is evident through an affiliation with Hackensack Meridian School of Medicine at Seton Hall University and a new affiliation with St. George’s University School of Medicine. Jersey Shore University Medical Center serves as an academic center dedicated to advancing medical knowledge, training future physicians and providing the community with access to promising medical breakthroughs.
Jersey Shore University Medical Center’s programs and services have received numerous national recognition, including designation as high-performing in cardiac, stroke, surgical and oncology services.
Jersey Shore University Medical Center recently completed the HOPE Tower Project – a $265 million 10-story medical office building that provides a new healing outpatient experience. Guided by a patient-centered approach towards care, and informed by the latest medical breakthroughs, HOPE Tower includes advanced imaging services, a clinical academic center, innovative stimulation laboratory, state-of-the-art amphitheater, specialty physician offices, a nine-level parking garage, and a 58,000 square foot cancer facility. The new cancer facility features a range of comprehensive treatment options, including surgical specialties, medical oncology, and the most advanced radiation therapy and minimally invasive interventional therapies. Nurse navigators guide patients through every step and provide an extra layer of support and coordination.